BioHealth News
Maryland’s Lt. Governor Miller Leads Maryland Delegation at World’s Largest Biotech Conference
BOSTON, MA – This week, Maryland Lt. Governor Aruna K. Miller led a Maryland delegation to the BIO International Convention in Boston, Massachusetts where she and members of the…
Read MoreSapio Sciences: Seamless AI-Native Drug Discovery with NVIDIA BioNeMo
BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This…
Read MoreBioPharmaDive: AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal
The British drugmaker is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer as well…
Read MorePhlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
Validation Completed for a Novel, Cost-Competitive Epinephrine Active Pharmaceutical Ingredient Process, Drug Master File Successfully Filed Richmond, Virginia, March 17, 2025 (GLOBE NEWSWIRE) --…
Read MoreThe Economic Power of NIH Grants: Why Sustained Investment Matters
The National Institutes of Health (NIH) is vital in driving scientific discovery and economic growth across the United States. Recent reports from United for…
Read MoreMotivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support
HONOLULU, HI, Mar. 12, 2025 – Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers who treat children with…
Read MoreWBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO
By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 12, 2025 - Gaithersburg’s Shuttle Pharmaceuticals Holdings Inc. (NASDAQ: SHPH) has brought in a…
Read MoreCEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it received comments from the U.S. Food and Drug Administration (FDA) on the confirmatory Registration…
Read MoreGain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read MoreGeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support tool…
Read MoreEmergent and Rocketvax Partner on Next-Gen Product Development
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across…
Read MoreRockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
Rockville, Md. (March 11, 2025) – Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic, platelet-derived, cellular therapeutics, is excited to announce…
Read MoreIonQ Raises Over $372 Million Via At-the-Market Equity Offering Program
COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ, Inc. (NYSE: IONQ), a leader in the quantum computing and quantum networking industries, today announced that under its “at-the-market” equity…
Read MoreSyngene Acquires its First Manufacturing Facility in Baltimore
BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited ('Syngene'), a global contract research, development, and manufacturing organization (CRDMO), today announced the acquisition of its…
Read MoreMCCC Trends in Life Science Event: Exploring Industry Shifts, Regulations, and Growth Opportunities – Rich Bendis Keynote Speaker
The life sciences industry is constantly evolving, influenced by new technologies, regulatory changes, and market dynamics. To help professionals stay informed, the MCCC Life…
Read More